Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
The office of Montana’s Republican attorney general is appealing a landmark climate change ruling that said state agencies aren't doing enough to protect 16 young plaintiffs from harm caused by global warming.
A coalition of environmental groups is calling on the federal government to enact emergency rules to protect a vanishing species of whale from lethal collisions with large ships.